glp 1 agonist stands for The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 and Anesthesia: Considerations and

Patients who view treatment as short-term may be less prepared for the long-term commitment required to maintain results

This vastly exceeded the 14.9% average weight loss with semaglutide 2.4 mg weekly in the STEP-1 trial

caution is needed for patients with a history of medullary thyroid cancer

Side effects remain one of the primary drivers of discontinuation

The widespread use of GLP-1 therapies, particularly in obesity, has raised questions about appropriate prescribing, long-term safety, and equitable access

However, these medications, including Ozempic and Zepbound, arent for everyone and can be pretty expensive, especially if you have to pay for them out of pocket